Fingerprint
Dive into the research topics of 'Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: Results of the TEMPO 3:4 Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: Results of the TEMPO 3:4 Trial
Ron T. Gansevoort, Esther Meijer, Arlene B. Chapman, Frank S. Czerwiec, Olivier Devuyst, Jared J. Grantham, Eiji Higashihara, Holly B. Krasa, John Ouyang, Ronald D. Perrone, Vicente E. Torres
Research output: Contribution to journal › Article › peer-review
24
Scopus
citations